QMAP: A Benchmark for Standardized Evaluation of Antimicrobial Peptide MIC and Hemolytic Activity Regression

preprint OA: closed
Full text JSON View at publisher

Abstract

ABSTRACT Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics, but progress in computational AMP discovery has been difficult to quantify due to inconsistent datasets and evaluation protocols. We introduce QMAP, a domain-specific benchmark for predicting AMP antimicrobial potency (MIC) and hemolytic toxicity (HC50) with homology-aware, predefined test sets. QMAP enforces strict sequence homology constraints between training and test data, ensuring that model performance reflects true generalization rather than overfitting. Applying QMAP, we reassess existing MIC models and establish baselines for MIC and HC50 regression. Results suggest limited progress over six years, poor performance for high-potency MIC regression, and low predictability for hemolytic activity, emphasizing the need for standardized evaluation and improved modeling approaches for highly potent peptides. We release a Python package facilitating practical adoption, and with a Rust-accelerated engine enabling efficient data manipulation, installable with pip install qmap-benchmark .
Full text 1,170 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT Antimicrobial peptides (AMPs) are promising alternatives to conventional antibiotics, but progress in computational AMP discovery has been difficult to quantify due to inconsistent datasets and evaluation protocols. We introduce QMAP, a domain-specific benchmark for predicting AMP antimicrobial potency (MIC) and hemolytic toxicity (HC50) with homology-aware, predefined test sets. QMAP enforces strict sequence homology constraints between training and test data, ensuring that model performance reflects true generalization rather than overfitting. Applying QMAP, we reassess existing MIC models and establish baselines for MIC and HC50 regression. Results show limited progress over six years, poor performance for high-potency MIC regression, and low predictability for hemolytic activity, emphasizing the need for standardized evaluation and improved modeling approaches for highly potent peptides. We release a Python package facilitating practical adoption, and with a Rust-accelerated engine enabling efficient data manipulation, installable with pip install qmap-benchmark. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00